Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2017 Mar;274(3):1291-1300.
doi: 10.1007/s00405-016-4273-1. Epub 2016 Aug 18.

Aspirin-exacerbated respiratory disease and current treatment modalities

Emine Güven Sakalar  1 , Nuray Bayar Muluk  2   3 , Murat Kar  4 , Cemal Cingi  5
Affiliations
Review

Aspirin-exacerbated respiratory disease and current treatment modalities

Emine Güven Sakalar et al. Eur Arch Otorhinolaryngol. 2017 Mar.

Abstract

Aspirin-exacerbated respiratory disease (AERD) refers to the combination of asthma, chronic rhinosinusitis with nasal polyposis, and acute upper and lower respiratory tract reactions to the ingestion of aspirin (acetylsalicylic acid, ASA) and other cyclooxygenase-1 inhibiting non-steroidal anti-inflammatory drugs. AERD affects 0.3-0.9 % of the general population. AERD generally occurs due to abnormalities in mediators and expression of arachidonic acid biosynthesis. Local IgE responses to staphylococcal enterotoxins may also be responsible for eosinophilic activation in the nasal polyp tissues of AERD patients. Clinical features of AERD include the onset of nasal congestion with anosmia, progressing to chronic pansinusitis and nasal polyps that regrow rapidly after surgery. Aspirin desensitization, Leukotriene-modifying agents, biologic agents, management of asthma, chronic rhinosinusitis, and nasal polyposis are recommended as treatment modalities. Immunotherapy is prescribed only to those AERD patients who experience clear seasonal or perennial allergy symptoms in addition to the symptoms attributable to chronic nasal polyposis. There are also investigational and dietary therapies. In this review, the important aspects of AERD will be presented, along with a literature survey.

Keywords: Aspirin (acetylsalicylic acid, ASA); Aspirin-exacerbated respiratory disease (AERD); Asthma; Chronic rhinosinusitis with nasal polyposis; Cyclooxygenase-1-inhibiting non-steroidal anti-inflammatory drugs.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Clin Exp Allergy. 2004 Aug;34(8):1270-5 - PubMed
    1. J Allergy Clin Immunol. 2013 Oct;132(4):856-65.e1-3 - PubMed
    1. Am J Respir Crit Care Med. 1998 Apr;157(4 Pt 1):1187-94 - PubMed
    1. Allergy Asthma Immunol Res. 2014 Jul;6(4):288-95 - PubMed
    1. Ann Intern Med. 1968 May;68(5):975-83 - PubMed

MeSH terms

LinkOut - more resources